Skip to main content
Journal ArticleOPEN ACCESS

A comparison of liprotamase, a non-porcine pancreatic enzyme replacement therapy, to porcine extracted pancrelipase in a noninferiority randomized clinical trial in patients with cystic fibrosis

  • Konstan M
  • Wagener J
  • Wilschanski M
  • et al.
Clinical Investigation (2018) 08(04)
DOI: 10.4172/clinical-investigation.1000141
N/ACitations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

… Concomitant medications for treatment of cystic fibrosis, including CF transmembrane conductance regulator (CFTR) modulators, GAS, and … Liprotamase failed to achieve the primary endpoint in the SOLUTION trial. The change from baseline CFA to end of study was minimal for …

Cite

CITATION STYLE

APA

Konstan, M. W., Wagener, J. S., Wilschanski, M., Laki, I., Boas, S. R., Sands, D., … Pennington, J. (2018). A comparison of liprotamase, a non-porcine pancreatic enzyme replacement therapy, to porcine extracted pancrelipase in a noninferiority randomized clinical trial in patients with cystic fibrosis. Clinical Investigation, 08(04). https://doi.org/10.4172/clinical-investigation.1000141

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free